JP2016190870A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016190870A5 JP2016190870A5 JP2016152831A JP2016152831A JP2016190870A5 JP 2016190870 A5 JP2016190870 A5 JP 2016190870A5 JP 2016152831 A JP2016152831 A JP 2016152831A JP 2016152831 A JP2016152831 A JP 2016152831A JP 2016190870 A5 JP2016190870 A5 JP 2016190870A5
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US8942208P | 2008-08-15 | 2008-08-15 | |
| US61/089,422 | 2008-08-15 | ||
| US27333209P | 2009-08-03 | 2009-08-03 | |
| US61/273,332 | 2009-08-03 | ||
| US23172509P | 2009-08-06 | 2009-08-06 | |
| US61/231,725 | 2009-08-06 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014092883A Division JP6034327B2 (ja) | 2008-08-15 | 2014-04-28 | 経口投与に好適なｇｃ−ｃ受容体アゴニストポリペプチドの安定な固体製剤 |
Related Child Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018070899A Division JP2018104469A (ja) | 2008-08-15 | 2018-04-02 | 経口投与に好適なｇｃ−ｃ受容体アゴニストポリペプチドの安定な固体製剤 |
| JP2018070898A Division JP6473532B2 (ja) | 2008-08-15 | 2018-04-02 | 経口投与に好適なｇｃ−ｃ受容体アゴニストポリペプチドの安定な固体製剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2016190870A JP2016190870A (ja) | 2016-11-10 |
| JP2016190870A5 true JP2016190870A5 (ja) | 2017-03-30 |
Family
ID=41666602
Family Applications (10)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011523004A Active JP5770629B2 (ja) | 2008-08-15 | 2009-08-14 | 経口投与に好適なｇｃ−ｃ受容体アゴニストポリペプチドの安定な固体製剤 |
| JP2014092883A Active JP6034327B2 (ja) | 2008-08-15 | 2014-04-28 | 経口投与に好適なｇｃ−ｃ受容体アゴニストポリペプチドの安定な固体製剤 |
| JP2016152831A Withdrawn JP2016190870A (ja) | 2008-08-15 | 2016-08-03 | 経口投与に好適なｇｃ−ｃ受容体アゴニストポリペプチドの安定な固体製剤 |
| JP2018070898A Active JP6473532B2 (ja) | 2008-08-15 | 2018-04-02 | 経口投与に好適なｇｃ−ｃ受容体アゴニストポリペプチドの安定な固体製剤 |
| JP2018070899A Withdrawn JP2018104469A (ja) | 2008-08-15 | 2018-04-02 | 経口投与に好適なｇｃ−ｃ受容体アゴニストポリペプチドの安定な固体製剤 |
| JP2019126707A Withdrawn JP2019163340A (ja) | 2008-08-15 | 2019-07-08 | 経口投与に好適なｇｃ−ｃ受容体アゴニストポリペプチドの安定な固体製剤 |
| JP2021018125A Withdrawn JP2021073297A (ja) | 2008-08-15 | 2021-02-08 | 経口投与に好適なｇｃ−ｃ受容体アゴニストポリペプチドの安定な固体製剤 |
| JP2022111842A Withdrawn JP2022132383A (ja) | 2008-08-15 | 2022-07-12 | 経口投与に好適なｇｃ－ｃ受容体アゴニストポリペプチドの安定な固体製剤 |
| JP2023209257A Withdrawn JP2024015361A (ja) | 2008-08-15 | 2023-12-12 | 経口投与に好適なｇｃ－ｃ受容体アゴニストポリペプチドの安定な固体製剤 |
| JP2025080475A Pending JP2025109853A (ja) | 2008-08-15 | 2025-05-13 | 経口投与に好適なｇｃ－ｃ受容体アゴニストポリペプチドの安定な固体製剤 |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011523004A Active JP5770629B2 (ja) | 2008-08-15 | 2009-08-14 | 経口投与に好適なｇｃ−ｃ受容体アゴニストポリペプチドの安定な固体製剤 |
| JP2014092883A Active JP6034327B2 (ja) | 2008-08-15 | 2014-04-28 | 経口投与に好適なｇｃ−ｃ受容体アゴニストポリペプチドの安定な固体製剤 |
Family Applications After (7)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018070898A Active JP6473532B2 (ja) | 2008-08-15 | 2018-04-02 | 経口投与に好適なｇｃ−ｃ受容体アゴニストポリペプチドの安定な固体製剤 |
| JP2018070899A Withdrawn JP2018104469A (ja) | 2008-08-15 | 2018-04-02 | 経口投与に好適なｇｃ−ｃ受容体アゴニストポリペプチドの安定な固体製剤 |
| JP2019126707A Withdrawn JP2019163340A (ja) | 2008-08-15 | 2019-07-08 | 経口投与に好適なｇｃ−ｃ受容体アゴニストポリペプチドの安定な固体製剤 |
| JP2021018125A Withdrawn JP2021073297A (ja) | 2008-08-15 | 2021-02-08 | 経口投与に好適なｇｃ−ｃ受容体アゴニストポリペプチドの安定な固体製剤 |
| JP2022111842A Withdrawn JP2022132383A (ja) | 2008-08-15 | 2022-07-12 | 経口投与に好適なｇｃ－ｃ受容体アゴニストポリペプチドの安定な固体製剤 |
| JP2023209257A Withdrawn JP2024015361A (ja) | 2008-08-15 | 2023-12-12 | 経口投与に好適なｇｃ－ｃ受容体アゴニストポリペプチドの安定な固体製剤 |
| JP2025080475A Pending JP2025109853A (ja) | 2008-08-15 | 2025-05-13 | 経口投与に好適なｇｃ－ｃ受容体アゴニストポリペプチドの安定な固体製剤 |
Country Status (32)
| Country | Link |
|---|---|
| US (7) | US20120213846A1 (ja) |
| EP (2) | EP2328601B1 (ja) |
| JP (10) | JP5770629B2 (ja) |
| KR (11) | KR20210043728A (ja) |
| CN (5) | CN105168114A (ja) |
| AU (1) | AU2009282446B2 (ja) |
| BR (1) | BRPI0917807A2 (ja) |
| CA (1) | CA2732892C (ja) |
| CL (1) | CL2011000314A1 (ja) |
| CO (1) | CO6351746A2 (ja) |
| CY (1) | CY1122801T1 (ja) |
| DK (1) | DK2328601T3 (ja) |
| EA (1) | EA201170337A1 (ja) |
| ES (1) | ES2785980T3 (ja) |
| GE (1) | GEP20156209B (ja) |
| HK (1) | HK1219062A1 (ja) |
| HR (1) | HRP20200512T2 (ja) |
| HU (1) | HUE049023T2 (ja) |
| IL (1) | IL211028A (ja) |
| LT (1) | LT2328601T (ja) |
| MX (4) | MX373366B (ja) |
| NZ (1) | NZ591713A (ja) |
| PE (2) | PE20110543A1 (ja) |
| PH (1) | PH12015501579B1 (ja) |
| PL (1) | PL2328601T3 (ja) |
| PT (1) | PT2328601T (ja) |
| RS (1) | RS60101B1 (ja) |
| SG (1) | SG193801A1 (ja) |
| SI (1) | SI2328601T1 (ja) |
| SM (1) | SMT202000179T1 (ja) |
| WO (1) | WO2010019266A2 (ja) |
| ZA (1) | ZA201101523B (ja) |
Families Citing this family (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX373366B (es) | 2008-08-15 | 2020-05-26 | Ironwood Pharmaceuticals Inc | Formulaciones que contienen linaclotida para administracion oral. |
| ES2608050T3 (es) | 2008-12-03 | 2017-04-05 | Synergy Pharmaceuticals Inc. | Formulaciones de agonistas de guanilato ciclasa C y métodos de uso |
| WO2011017502A2 (en) * | 2009-08-06 | 2011-02-10 | Ironwood Pharmaceuticals, Inc. | Linaclotide-containing formulations for oral administration |
| US20130045239A1 (en) * | 2009-08-13 | 2013-02-21 | Ironwood Pharmaceuticals, Inc. | Method for Modulating the Pharmacodynamic Effect of Orally Administered Guanylate Cyclase Receptor Agonists |
| EP2521561B1 (en) * | 2009-11-03 | 2017-07-26 | Ironwood Pharmaceuticals, Inc. | Linaclotide for the treatment of chronic constipation |
| UA114274C2 (uk) | 2009-11-09 | 2017-05-25 | Айронвуд Фармасьютікалз, Інк. | Лікування шлунково-кишкових розладів |
| RU2012128509A (ru) | 2009-12-07 | 2014-01-20 | Айронвуд Фармасьютикалз, Инк. | Способы лечения заболеваний желудочно-кишечного тракта |
| ES2638589T3 (es) | 2010-02-17 | 2017-10-23 | Ironwood Pharmaceuticals, Inc. | Tratamientos para trastornos intestinales |
| ES2919136T3 (es) * | 2010-08-11 | 2022-07-22 | Ironwood Pharmaceuticals Inc | Formulaciones estables de linaclotida |
| EP2613794A1 (en) * | 2010-09-11 | 2013-07-17 | Ironwood Pharmaceuticals, Inc. | Treatment of constipation-predominant irritable bowel syndrome |
| US9616097B2 (en) * | 2010-09-15 | 2017-04-11 | Synergy Pharmaceuticals, Inc. | Formulations of guanylate cyclase C agonists and methods of use |
| WO2012037380A2 (en) | 2010-09-15 | 2012-03-22 | Synergy Pharmaceuticals Inc. | Formulations of guanylate cyclase c agonists and methods of use |
| US9303066B2 (en) | 2011-05-11 | 2016-04-05 | Ironwood Pharmaceuticals, Inc. | Treatments for gastrointestinal disorders |
| US9650417B2 (en) | 2011-05-11 | 2017-05-16 | Ironwood Pharmaceuticals, Inc. | Treatments for gastrointestinal disorders |
| US9527887B2 (en) | 2011-06-08 | 2016-12-27 | Ironwood Pharmaceutical, Inc. | Treatments for gastrointestinal disorders |
| WO2012170804A1 (en) * | 2011-06-08 | 2012-12-13 | Ironwood Pharmaceuticals, Inc. | Treatments for gastrointestinal disorders |
| CA2846230A1 (en) | 2011-08-17 | 2013-02-21 | Ironwood Pharmaceuticals, Inc. | Treatments for gastrointestinal disorders |
| JP5553132B2 (ja) * | 2011-09-30 | 2014-07-16 | アステラス製薬株式会社 | 粒子状医薬組成物 |
| JP2016521249A (ja) * | 2012-07-12 | 2016-07-21 | フォレスト ラボラトリーズ ホールディングス リミテッド | リナクロチド組成物 |
| EP2950803A1 (en) * | 2013-01-30 | 2015-12-09 | Sandoz AG | Crystalline form of linaclotide |
| AU2014305843B2 (en) | 2013-08-09 | 2019-08-29 | Ardelyx, Inc. | Compounds and methods for inhibiting phosphate transport |
| UA119335C2 (uk) | 2013-12-11 | 2019-06-10 | Айронвуд Фармасьютикалз, Інк. | Композиції лінаклотиду з затриманим вивільненням |
| US10272131B2 (en) * | 2014-08-11 | 2019-04-30 | Sun Pharmaceutical Industries Ltd. | Linaclotide stable composition |
| ES2630106T3 (es) * | 2014-10-07 | 2017-08-18 | Cyprumed Gmbh | Formulaciones farmacéuticas para la administración oral de fármacos peptídicos o proteicos |
| CN104569245A (zh) * | 2014-12-08 | 2015-04-29 | 江苏泰洁检测技术有限公司 | 一种工作场所脂肪族胺类中环己胺浓度测定方法 |
| US20180008547A1 (en) * | 2015-02-02 | 2018-01-11 | Aurobindo Pharma Ltd | Stable Compositions comprising Linaclotide |
| EP3302440B1 (en) * | 2015-06-05 | 2021-01-06 | Ironwood Pharmaceuticals, Inc. | Modified or targeted release formulations of linaclotide |
| EP3359181A1 (en) | 2015-10-07 | 2018-08-15 | Cyprumed GmbH | Pharmaceutical formulations for the oral delivery of peptide drugs |
| MA47112A (fr) | 2016-12-21 | 2019-10-30 | Ironwood Pharmaceuticals Inc | Procédés de traitement du syndrome du côlon irritable avec des formulations à libération modifiée ou retardée de linaclotide |
| CN107669700A (zh) * | 2017-09-14 | 2018-02-09 | 湖南晓林生物科技发展有限公司 | 一种治疗溃疡性结肠炎的药物及其制备方法 |
| WO2020012243A2 (en) | 2018-07-09 | 2020-01-16 | Abbott Laboratories Gmbh | Pharmaceutical composition containing a peptide |
| US20200368223A1 (en) | 2019-05-21 | 2020-11-26 | Ardelyx, Inc. | Methods for inhibiting phosphate transport |
| CN112121021B (zh) * | 2019-06-24 | 2022-03-25 | 深圳翰宇药业股份有限公司 | 一种含利那洛肽的药物组合物及其制备方法 |
| JP2021104941A (ja) * | 2019-12-26 | 2021-07-26 | ニプロ株式会社 | 薬物高含有量錠剤及びその製造方法 |
| WO2022002369A1 (en) * | 2020-06-30 | 2022-01-06 | Ocvirk Soeren | Pharmaceutical composition comprising a combination of a guanylate cyclase c (gucy2c) agonist and a short-chain fatty acid or prodrug thereof |
| CN113616616A (zh) * | 2021-09-07 | 2021-11-09 | 四川国为制药有限公司 | 一种利那洛肽胶囊制剂及其制备方法 |
| US20230106943A1 (en) * | 2021-09-17 | 2023-04-06 | Peptilogics, Inc. | Engineered antimicrobial peptides and usage thereof |
| CN114632141B (zh) * | 2022-04-19 | 2023-08-01 | 苏州中化药品工业有限公司 | 一种含利那洛肽的药物组合物、胶囊制剂及其制备方法 |
| CN116672309A (zh) * | 2023-07-26 | 2023-09-01 | 北京普诺旺康医药科技有限公司 | 干混悬药物组合物 |
Family Cites Families (71)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH658973A5 (fr) | 1983-12-29 | 1986-12-31 | Nestle Sa | Produit aromatisant. |
| JPS6197229A (ja) * | 1984-10-18 | 1986-05-15 | Chugai Pharmaceut Co Ltd | 安定なエリトロポエチン製剤 |
| DE3729863A1 (de) * | 1987-09-05 | 1989-03-16 | Boehringer Mannheim Gmbh | Stabilisierte erythropoietin-lyophilisate |
| JPS649938A (en) | 1987-06-30 | 1989-01-13 | Agency Ind Science Techn | Oral ingestive composition |
| CA2028848A1 (en) | 1989-04-11 | 1990-10-12 | Tapan Audhya | Lyophilized peptide formulations |
| IT1240314B (it) | 1989-09-28 | 1993-12-07 | Immunobiology Research Institutes, Inc. | Formulazioni acquose stabilizzate di piccoli peptidi. |
| US5221495A (en) | 1990-04-13 | 1993-06-22 | Colgate-Palmolive Company | Enzyme stabilizing composition and stabilized enzyme containing built detergent compositions |
| US5451410A (en) * | 1993-04-22 | 1995-09-19 | Emisphere Technologies, Inc. | Modified amino acids for encapsulating active agents |
| US6284727B1 (en) | 1993-04-07 | 2001-09-04 | Scios, Inc. | Prolonged delivery of peptides |
| US5681811A (en) | 1993-05-10 | 1997-10-28 | Protein Delivery, Inc. | Conjugation-stabilized therapeutic agent compositions, delivery and diagnostic formulations comprising same, and method of making and using the same |
| IL115592A (en) * | 1994-10-13 | 2000-07-26 | Novo Nordisk As | Stabilized pharmaceutical formulation comprising a growth hormone and leucine |
| US5654278A (en) * | 1994-10-13 | 1997-08-05 | Novo Nordisk A/S | Composition and method comprising growth hormone and leucine |
| US5593696A (en) * | 1994-11-21 | 1997-01-14 | Mcneil-Ppc, Inc. | Stabilized composition of famotidine and sucralfate for treatment of gastrointestinal disorders |
| US5904935A (en) | 1995-06-07 | 1999-05-18 | Alza Corporation | Peptide/protein suspending formulations |
| ZA965368B (en) * | 1995-07-14 | 1997-01-14 | Novo Nordisk As | A pharmaceutical formulation |
| US5932547A (en) | 1996-07-03 | 1999-08-03 | Alza Corporation | Non-aqueous polar aprotic peptide formulations |
| US5916582A (en) | 1996-07-03 | 1999-06-29 | Alza Corporation | Aqueous formulations of peptides |
| SK284490B6 (sk) | 1996-07-03 | 2005-05-05 | Alza Corporation | Stabilná nevodná formulácia a spôsob jej prípravy |
| US20020151502A1 (en) * | 1997-10-09 | 2002-10-17 | Albert Sattin | Tri-peptides for neurological and neurobehavior applications |
| US6541606B2 (en) | 1997-12-31 | 2003-04-01 | Altus Biologics Inc. | Stabilized protein crystals formulations containing them and methods of making them |
| US6087478A (en) | 1998-01-23 | 2000-07-11 | The Rockefeller University | Crystal of the N-terminal domain of a STAT protein and methods of use thereof |
| WO2000004880A1 (en) | 1998-07-23 | 2000-02-03 | Novo Nordisk A/S | A wet granulation method for preparing a stable pharmaceutical formulation |
| BR9913302A (pt) * | 1998-09-04 | 2002-09-24 | Gaplast Gmbh | Recipiente |
| AU766293B2 (en) | 1998-11-27 | 2003-10-16 | Kanji Takada | An oral formulation for gastrointestinal drug delivery |
| WO2001052937A1 (en) | 2000-01-24 | 2001-07-26 | Medtronic Minimed, Inc. | Mixed buffer system for stabilizing polypeptide formulations |
| JP4711520B2 (ja) * | 2000-03-21 | 2011-06-29 | 日本ケミカルリサーチ株式会社 | 生理活性ペプチド含有粉末 |
| EP1299101A4 (en) | 2000-06-28 | 2004-06-16 | Teva Pharma | CARVEDILOL |
| FR2811884B1 (fr) | 2000-07-21 | 2003-01-31 | Oreal | Utilisation en cosmetique de betainates d'amidon et composition les comprenant associes a au moins un agent benefique pour les matieres keratiniques |
| US6613308B2 (en) | 2000-09-19 | 2003-09-02 | Advanced Inhalation Research, Inc. | Pulmonary delivery in treating disorders of the central nervous system |
| WO2002026248A1 (en) | 2000-09-29 | 2002-04-04 | Cognetix, Inc. | Stable peptide formulations |
| AU2002241723A1 (en) | 2000-12-21 | 2002-07-24 | Inhale Therapeutic Systems, Inc. | Storage stable powder compositions of interleukin-4 receptor |
| CA2435835A1 (en) | 2001-02-02 | 2002-08-15 | Pharmacia Corporation | Uroguanylin and cyclooxygenase-2 inhibitor combinations for inhibition of intestinal cancer |
| GB0104371D0 (en) | 2001-02-22 | 2001-04-11 | Clariant Int Ltd | Color improving stabilizing compositions comprising leucine |
| US6573237B2 (en) | 2001-03-16 | 2003-06-03 | Eli Lilly And Company | Protein formulations |
| CA2905585C (en) | 2001-03-29 | 2020-02-18 | Synergy Pharmaceuticals, Inc. | Guanylate cyclase receptor agonists for the treatment and/or prevention of cancer or polyps |
| AU2002355542A1 (en) | 2001-08-09 | 2003-02-24 | Doctor's Signature Sales And Marketing International Corp. ((Dba)) Life Force International | Protonic formulation |
| US20030104996A1 (en) | 2001-08-30 | 2003-06-05 | Tiansheng Li | L-methionine as a stabilizer for NESP/EPO in HSA-free formulations |
| US20040161776A1 (en) | 2001-10-23 | 2004-08-19 | Maddon Paul J. | PSMA formulations and uses thereof |
| BR0215218A (pt) | 2001-12-21 | 2004-11-16 | Novo Nordisk As | Composição aquosa lìquida, método para a preparação da mesma, uso de uma composição, e, métodos para a inibição da coagulação do sangue em um indivìduo, e inibição de reações mediadas pelo fator de tecido em um indivìduo |
| JP2003201256A (ja) | 2001-12-28 | 2003-07-18 | Hisamitsu Pharmaceut Co Inc | 大腸送達性経口医薬製剤、大腸癌治療用経口医薬製剤および大腸炎治療用経口医薬製剤 |
| DE10261126A1 (de) * | 2002-08-13 | 2004-03-04 | Aventis Behring Gmbh | Lagerungsstabile, flüssige Fibrinogen-Formulierung |
| EP1572163A1 (en) | 2002-12-11 | 2005-09-14 | Pfizer Products Inc. | Controlled-release of an active substance into a high fat environment |
| US7371727B2 (en) | 2003-01-28 | 2008-05-13 | Microbia, Inc. | Methods and compositions for the treatment of gastrointestinal disorders |
| SI1911763T1 (sl) * | 2003-01-28 | 2010-11-30 | Ironwood Pharmaceuticals Inc | Sestavki za zdravljenje gastrointestinalnih motenj |
| US7304036B2 (en) | 2003-01-28 | 2007-12-04 | Microbia, Inc. | Methods and compositions for the treatment of gastrointestinal disorders |
| US7772188B2 (en) | 2003-01-28 | 2010-08-10 | Ironwood Pharmaceuticals, Inc. | Methods and compositions for the treatment of gastrointestinal disorders |
| ATE390142T1 (de) | 2003-05-14 | 2008-04-15 | Indus Biotech Pvt Ltd | Synergistische zusammensetzung zur behandlung von diabetes mellitus |
| US8119595B2 (en) | 2003-06-10 | 2012-02-21 | Lg Life Sciences, Ltd. | Stable, aqueous solution of human erythropoietin, not containing serum albumin |
| ES2391974T3 (es) | 2003-06-13 | 2012-12-03 | Ironwood Pharmaceuticals, Inc. | Procedimientos y composiciones para el tratamiento de trastornos gastrointestinales |
| US7494979B2 (en) | 2003-06-13 | 2009-02-24 | Ironwood Pharmaceuticals, Inc. | Method for treating congestive heart failure and other disorders |
| KR100560697B1 (ko) | 2003-08-06 | 2006-03-16 | 씨제이 주식회사 | 알부민을 함유하지 않는 에리스로포이에틴 제제 |
| DE202004020676U1 (de) | 2004-03-10 | 2005-11-10 | Bioceuticals Arzneimittel Ag | Erythropoietin-Flüssigformulierung |
| KR100770362B1 (ko) | 2004-12-30 | 2007-10-26 | (주)두비엘 | 분무건조 고분자형 콜렉틴족 단백질 및 그의 제조방법 |
| CA2619650A1 (en) | 2005-08-19 | 2007-02-22 | Microbia, Inc. | Methods and compositions for the treatment of gastrointestinal disorders |
| WO2007044375A2 (en) | 2005-10-06 | 2007-04-19 | Nastech Pharmaceutical Company Inc. | Pth formulations and methods of use |
| AU2006338839A1 (en) * | 2006-02-23 | 2007-08-30 | Iomedix Sleep International Srl | Compositions and methods for the induction and maintenance of quality sleep |
| CA2652677A1 (en) | 2006-02-24 | 2007-09-07 | Ironwood Pharmaceuticals, Inc. | Methods and compositions for the treatment of gastrointestinal disorders |
| ITMI20060629A1 (it) | 2006-03-31 | 2007-10-01 | Daniele Giovannone | Composizioni solide orali a base di s-adenosilmetionina e processo per il loro ottenimento |
| WO2008006125A1 (en) | 2006-07-10 | 2008-01-17 | Österreichische Akademie der Wissenschaften | Antimicrobial peptides |
| CA2670821C (en) | 2006-08-09 | 2012-05-15 | Intarcia Therapeutics, Inc. | Osmotic delivery systems and piston assemblies |
| RU2493868C2 (ru) | 2006-08-31 | 2013-09-27 | Новартис Аг | ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ, СОДЕРЖАЩИЕ чГР, ДЛЯ ПЕРОРАЛЬНОГО ВВЕДЕНИЯ |
| WO2008078189A2 (en) | 2006-12-20 | 2008-07-03 | Bayer Healthcare Llc | Factor vii and viia compositions |
| US8779090B2 (en) | 2007-02-26 | 2014-07-15 | Ironwood Pharmaceuticals, Inc. | Methods and compositions for the treatment of heart failure and other disorders |
| MX2009013293A (es) | 2007-06-04 | 2010-02-15 | Synergy Pharmaceuticals Inc | Agonistas de guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos. |
| MX373366B (es) | 2008-08-15 | 2020-05-26 | Ironwood Pharmaceuticals Inc | Formulaciones que contienen linaclotida para administracion oral. |
| WO2010027405A2 (en) * | 2008-09-04 | 2010-03-11 | Ironwood Pharmaceuticals, Inc. | Stable solid formulations of gc-c receptor agonist polypeptides suitable for oral administration |
| EP2331077A2 (en) | 2008-09-04 | 2011-06-15 | Ironwood Pharmaceuticals, Inc. | Stable forlulation comprising therapeutic polypeptides for oral administration |
| ES2608050T3 (es) * | 2008-12-03 | 2017-04-05 | Synergy Pharmaceuticals Inc. | Formulaciones de agonistas de guanilato ciclasa C y métodos de uso |
| US20130012454A1 (en) * | 2009-07-06 | 2013-01-10 | Ironwood Pharmaceuticals, Inc. | Orally Disintegrating Compositions of Linaclotide |
| WO2011019819A1 (en) | 2009-08-12 | 2011-02-17 | Forest Laboratories Holdings Limited | Orally disintegrating compositions of linaclotide |
| WO2011017502A2 (en) | 2009-08-06 | 2011-02-10 | Ironwood Pharmaceuticals, Inc. | Linaclotide-containing formulations for oral administration |
-
2009
- 2009-08-14 MX MX2015004911A patent/MX373366B/es unknown
- 2009-08-14 KR KR1020217010732A patent/KR20210043728A/ko not_active Ceased
- 2009-08-14 KR KR1020117005886A patent/KR101704832B1/ko active Active
- 2009-08-14 CN CN201510363805.7A patent/CN105168114A/zh active Pending
- 2009-08-14 KR KR1020177002833A patent/KR20170016522A/ko not_active Ceased
- 2009-08-14 CN CN201810378167.XA patent/CN109010254A/zh active Pending
- 2009-08-14 MX MX2011001620A patent/MX2011001620A/es active IP Right Grant
- 2009-08-14 NZ NZ591713A patent/NZ591713A/xx unknown
- 2009-08-14 KR KR1020227022715A patent/KR20220100101A/ko not_active Ceased
- 2009-08-14 US US13/059,154 patent/US20120213846A1/en not_active Abandoned
- 2009-08-14 MX MX2020005326A patent/MX390359B/es unknown
- 2009-08-14 ES ES09789142T patent/ES2785980T3/es active Active
- 2009-08-14 PE PE2011000151A patent/PE20110543A1/es active IP Right Grant
- 2009-08-14 SI SI200932048T patent/SI2328601T1/sl unknown
- 2009-08-14 SM SM20200179T patent/SMT202000179T1/it unknown
- 2009-08-14 HU HUE09789142A patent/HUE049023T2/hu unknown
- 2009-08-14 RS RS20200341A patent/RS60101B1/sr unknown
- 2009-08-14 KR KR1020177034889A patent/KR20170138580A/ko not_active Ceased
- 2009-08-14 PL PL09789142T patent/PL2328601T3/pl unknown
- 2009-08-14 EA EA201170337A patent/EA201170337A1/ru unknown
- 2009-08-14 BR BRPI0917807-4A patent/BRPI0917807A2/pt not_active Application Discontinuation
- 2009-08-14 KR KR1020207025119A patent/KR20200105730A/ko not_active Ceased
- 2009-08-14 KR KR1020187036664A patent/KR20180137043A/ko not_active Ceased
- 2009-08-14 EP EP09789142.8A patent/EP2328601B1/en active Active
- 2009-08-14 MX MX2019013628A patent/MX385591B/es unknown
- 2009-08-14 JP JP2011523004A patent/JP5770629B2/ja active Active
- 2009-08-14 PT PT97891428T patent/PT2328601T/pt unknown
- 2009-08-14 US US12/541,410 patent/US8802628B2/en active Active
- 2009-08-14 CA CA2732892A patent/CA2732892C/en active Active
- 2009-08-14 KR KR1020217037760A patent/KR20210145307A/ko not_active Ceased
- 2009-08-14 HR HRP20200512TT patent/HRP20200512T2/hr unknown
- 2009-08-14 KR KR1020197037905A patent/KR20200000462A/ko not_active Ceased
- 2009-08-14 CN CN200980140931.9A patent/CN102186490B/zh active Active
- 2009-08-14 GE GEAP200912142A patent/GEP20156209B/en unknown
- 2009-08-14 WO PCT/US2009/004675 patent/WO2010019266A2/en not_active Ceased
- 2009-08-14 CN CN202210243774.1A patent/CN114668711A/zh active Pending
- 2009-08-14 CN CN202311333813.8A patent/CN117530912A/zh active Pending
- 2009-08-14 SG SG2013062054A patent/SG193801A1/en unknown
- 2009-08-14 AU AU2009282446A patent/AU2009282446B2/en active Active
- 2009-08-14 KR KR1020237004083A patent/KR20230025926A/ko not_active Ceased
- 2009-08-14 EP EP20152529.2A patent/EP3701962A1/en active Pending
- 2009-08-14 DK DK09789142.8T patent/DK2328601T3/da active
- 2009-08-14 PE PE2015000686A patent/PE20151205A1/es unknown
- 2009-08-14 LT LTEP09789142.8T patent/LT2328601T/lt unknown
- 2009-08-14 KR KR1020247004930A patent/KR20240025699A/ko active Pending
-
2011
- 2011-02-03 IL IL211028A patent/IL211028A/en active IP Right Grant
- 2011-02-14 CL CL2011000314A patent/CL2011000314A1/es unknown
- 2011-02-18 CO CO11019927A patent/CO6351746A2/es active IP Right Grant
- 2011-02-25 ZA ZA2011/01523A patent/ZA201101523B/en unknown
-
2013
- 2013-03-15 US US13/837,631 patent/US20130273169A1/en not_active Abandoned
-
2014
- 2014-04-28 JP JP2014092883A patent/JP6034327B2/ja active Active
-
2015
- 2015-07-16 PH PH12015501579A patent/PH12015501579B1/en unknown
-
2016
- 2016-06-22 HK HK16107217.4A patent/HK1219062A1/zh unknown
- 2016-08-03 JP JP2016152831A patent/JP2016190870A/ja not_active Withdrawn
-
2018
- 2018-04-02 JP JP2018070898A patent/JP6473532B2/ja active Active
- 2018-04-02 JP JP2018070899A patent/JP2018104469A/ja not_active Withdrawn
- 2018-09-13 US US16/129,951 patent/US20190029967A1/en not_active Abandoned
-
2019
- 2019-07-08 JP JP2019126707A patent/JP2019163340A/ja not_active Withdrawn
-
2020
- 2020-04-13 CY CY20201100342T patent/CY1122801T1/el unknown
-
2021
- 2021-02-08 JP JP2021018125A patent/JP2021073297A/ja not_active Withdrawn
- 2021-06-02 US US17/336,462 patent/US20210290554A1/en not_active Abandoned
-
2022
- 2022-01-07 US US17/570,713 patent/US20220125734A1/en not_active Abandoned
- 2022-07-12 JP JP2022111842A patent/JP2022132383A/ja not_active Withdrawn
-
2023
- 2023-04-14 US US18/134,977 patent/US20230310329A1/en not_active Abandoned
- 2023-12-12 JP JP2023209257A patent/JP2024015361A/ja not_active Withdrawn
-
2025
- 2025-05-13 JP JP2025080475A patent/JP2025109853A/ja active Pending